Skip to main content
Title
Adjunct Associate Professor
Office Location
Pharmacoepidemiology
Phone Number
(310) 918-6530
Email
crowan@cohrdata.com

Christopher G. Rowan, PhD

Faculty

About
Christopher G. Rowan PhD, is a pharmacoepidemiologist, biostatistician, and outcomes
researcher by training. He is the Founder and President of Collaborative Healthcare Research &
Data Analytics (COHRDATA). His research vision is to generate evidence, using real-world data
that healthcare decision makers (i.e., patients, providers, payers, and regulators) and industry
partners may use to guide evidence-based decisions.

Chris is experienced conducting observational research using large electronic health record
(EHR) and administrative claims databases. He has experience in pharmacoepidemiology,
comparative effectiveness research, comparative safety research, predictive modeling,
methodologic investigations, health services research, and health economic impact research.
His research proficiencies include study design, research methodology, statistical analysis,
causal inference, and interpretation of observational research.

Chris has a strong publication track-record. Some of his recent publications include:
comparative effectiveness/safety studies in diabetes, nephrology, cardiovascular and
autoimmune diseases; predictive modeling studies in COPD and hypertension; and
methodologic investigations involving propensity scores and an assessment of the validity of
EHR prescribing data.

Chris received his Doctor of Philosophy in Epidemiology with a minor in Biostatistics from the
University of Pennsylvania – Perelman School of Medicine, Department of Biostatistics and
Epidemiology, Center for Clinical Epidemiology and Biostatistics (CCEB). He received the Saul
Winegrad award for outstanding dissertation. Chris conducted a pre-doctoral fellowship at the
FDA in the Division of Drug Risk Evaluation. He is an Associate Faculty (adjunct) at the
Institute for Health, Health Care Policy, and Aging Research at Rutgers and active member of
ISPE. He serves as a regular reviewer for Pharmacoepidemiology and Drug Safety.